HB 666 Public Health Expensive Drugs Manufacturer Reporting and Drug Price Transparency Advisory Committee
Maryland 2017 Regular Session
Bill Texts
Introduced
02/01/2017
Weigh In
Spread the Word!
Twitter
Gettr
Embed Code
Sponsors (74)
Show all sponsors
Track This Bill
Get notified when this bill is updated
Subject(s)
Public Health
Attorney General
Auditors And Audits
Committees And Commissions
Consumer Protection
Courts
Disclosure
Drugs
Electronic Communication
Electronic Government
Fees
General Assembly
Governor
Health And Mental Hygiene, Department Of
Identification
Inspections
Penalties And Sentences
Pharmacists And Pharmacies
Public Information
Reports
Retail Sales
Rules And Regulations